A novel COMP mutation in a pseudoachondroplasia family of Chinese origin by Dai, Li et al.
CASE REPORT Open Access
An o v e lCOMP mutation in a pseudoachondroplasia
family of Chinese origin
Li Dai
1*, Liang Xie
1, Yanping Wang
1, Meng Mao
2, Nana Li
1, Jun Zhu
3*, Christopher Kim
4 and Yawei Zhang
4
Abstract
Background: Pseudoachondroplasia (PSACH) is caused exclusively by mutations in the gene for cartilage
oligomeric matrix protein (COMP). Only a small number of studies have documented the clinical phenotype and
genetic basis in Chinese PSACH patients.
Case presentation: We investigated a four-generation PSACH pedigree of Chinese Han origin. Two patients and
two unaffected individuals were recruited for clinical evaluation and molecular genetic analysis. The genomic DNA
was extracted from peripheral blood leukocytes. Polymerase chain reaction (PCR) was adopted to amplify the 8-19
exons of COMP gene. Then the products were sequenced bi-directionally for screening mutation. Clinical
evaluation revealed that PSACH patients in this pedigree had a severe disproportionate short stature (-10SD). A
heterozygous TGTCCCTGG insertion in exon 13, between nucleotide 1352T and 1353G, were identified in the
patients except the unaffected individuals, which resulted in a three-amino-acid insertion (451V_452P ins VPG) in
the sixth calmodulin-like repeat of the COMP protein.
Conclusion: This c. 1352_1353ins TGTCCCTGG is a novel mutation responsible for severe familial PSACH.
Background
Pseudoachondroplasia (PSACH, OMIM 177170) is a
rare autosomal dominant osteochondrodysplasia charac-
terized by typical disproportionate short stature, brachy-
dactyly, lower limbs anomalies, joint laxity, scoliosis,
early onset osteoarthritis, epiphyseal and metaphyseal
abnormalities. It is estimated to affect at least 1 in
20,000 persons [1,2]. The affected individual has a nor-
mal length at birth,and growth retardation generally will
not be recognized until two or three years of age. Nota-
bly, all patients have normal craniofacial appearance and
intelligence [1,3-5].
The PSACH gene was initially localized to chromo-
some 19 in 1993 [6,7]. Mutations on the Cartilage Oligo-
meric Matrix Protein (COMP) gene were subsequently
found to cause PSACH and another skeletal dysplasia,
multiple epiphyseal dysplasia [8,9]. COMP protein is a
large secreted pentameric glycoprotein of the thrombos-
pondin family, expressed in the extracellular matrix
(ECM) surrounding the cells that make up ligaments and
tendons. COMP monomer consists of an amino-terminal
domain, four type IIepidermal growth like repeats, eight
type III calmodulin-like repeats (CLRs), and a carboxyl-
terminal globular domain. Numerous mutations of
COMP gene have been found to date, most of them
occur in the CLR regions (~85%), while others in the C-
terminal globular domain (~15%) (the Human Gene
Mutation Database, http://www.hgmd.cf.ac.uk/ac/index.
php). Although the normal function is not fully known,
the pathological link between gene mutation, protein
alteration, abnormal cell growth and PSACH has been
established [1,10-17]. More than 60 COMP mutations
have been identified to be with PSACH [10,18], but only
a few in Chinese patients [19,20]. Severe short stature (-6
SD) in PSACH has been associated with mutations in
exon 13, particularly in the region encoding CLR7 of
COMP protein [21]. Elliott AM et al recently detected
the c.812A®Ti ne x o n8i nas p o r a d i cI n u i tP S A C H
patient with severe short stature (-7.5 SD) [22]. In the
present study, we examined the COMP gene for muta-
tions in a Chinese family affected by severe PSACH.
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Subjects and methods
This family was initially contacted in the Sichuan pro-
vince through a member hospital in the Chinese Birth
Defects Monitoring Network. PSACH disorder was
transmitted through at least four generations in this
family. (Figure 1) After informed consent, two affected
(III 1 and IV 2) and two healthy persons (III 3 and IV
4) received a comprehensive physical examination and
had blood samples taken for mutation screening. The
clinical records and radiographic images were published
under the patients’ written permission. This study was
approved by the Research Ethics Committee of Sichuan
University.
Using a commercially available kit (Bio Teke, Beijing,
China), genomic DNA was isolated from blood samples
utilizing the standard protocol provided by the manufac-
turer of the kit. The procedure used for amplifying
COMP exons 8-19 (accession number NM000095) and
PCR is outlined previously [23]. The resulting product
was purified, separated by PAGE, and sequenced bi-
directionally using an ABI 3730xl sequencer.
Clinical features and skeletal radiographic findings
Pedigree analysis revealed six individuals affected by
severe short stature within a span of four generations
and the disorder exhibited dominant autosomal trans-
mission. All affected individuals demonstrated the typi-
cal characteristics of PSACH: disproportionate short-
limb dwarfing, short upper limbs, lower limb abnormi-
ties, waddling gait, but normal facial features and intelli-
gence. The abnormalities of the affected members in
this family appeared at about one year of age, usually
presenting as difficulties in learning to walk and delayed
growth compared with normal children. The proband
(III 1, Figure 1) was 99.6 cm tall at 45 years of age
(-10.6 SD on a normal growth curve of rural Chinese
male adults [24]; -1 SD on PSACH curve [25]), less than
the average height of 101.8 cm of typical rural-born 4-
year-old boys [24]. He had strikingly short limbs (upper
limb length 41.2 cm), small hands, short fingers, crus
varum and waddling gait. A lateral spine radiograph
(Figure 2) indicated platyspondyly and anterior beaking
of the vertebrae. His phalanges and metacarpals were
short with cone-shaped epiphyses. (Figure 2) The AP
view of pelvis radiograph (Figure 2) showed small
femoral heads, irregular acetabulae, enlarged acetabular
angles and widened symphysis pubis. His affected
daughter (IV2, Figure 1) demonstrated similar character-
istics, (Figure 2) albeit somewhat more severe than her
father. She was only 96 cm tall (-11.2 SD on a normal
growth curve of rural Chinese females at 16 years [26];
-1 SD on PSACH curve [24]) when was referred to hos-
pital at 16 years of age, which is comparable to the
height of a 3-year-old rural-born girl, far shorter than
the 156 cm average height of 16-year-old rural-born
girls [24]. The proband’s brother (III6, Figure 1, died
two years ago) was afflicted by a shorter stature.
Mutational analysis of the COMP gene
After sequencing the COMP exons 8-19 in the two
patients and two unaffected individuals, a heterozygous
9 bp insertion (c.1352_1353insTGTCCCTGG) was iden-
tified between nucleotide 1352T and 1353G in exon13,
which is located at the end of the sixth repeat of the
type-3 calcium-like repeat region of the COMP gene.
(Figure 3) As a consequence, three additional amino
acids, valine, proline and glycine, were inserted between
residues 451V and 452P of the COMP protein
(p.451V_452PinsVPG). A recent analysis indicated that
the residues 451V and 452P are in a calcium-binding
pocket domain of COMP protein [27]. The result was
confirmed by repeat sequence analysis.
Conclusion
Up to now, COMP i st h eo n l yg e n ek n o w nt ob ea s s o -
ciated with pseudoachondroplasia. COMP mutations
and pathological consequences have been extensively
studied in Caucasians, but a few in the Chinese popula-
tion. Besides the c.815C®Ti ne x o n8[ 1 9 ]a n dt h e
c.1447-1455del [20] in exon 13 of COMP gene reported
lately in Chinese PSACH patients, we identified the c.
1352_1353insTGTCCCTGG within exon 13 of COMP
that contributes to severe PSACH phenotype in a Han
Chinese pedigree. This novel trinucleotide expansion
was located in the region coding the sixth CLR (p.
451V_452PinsVPG) and expands the knowledge of
COMP mutations leading to PSACH.
PSACH mutations are located in exons 8-14 of COMP
gene encoding the type III CLRs of COMP protein
[3,18,28]. The most frequent mutation, present in one
third of PSACH patients, is the deletion of GAC
Figure 1 Pedigree chart of a Han Chinese pesudoachoplasia
family.
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Page 2 of 5(c.1405-1419delGAC) in a very short triplet repeat
(GAC5), which encodes five consecutive aspartic acid
residues within the CLR7 of the protein, usually referred
as p.469delD, p.473 delD or p.del D469-473 [3,8,29,30].
Most other COMP mutations involve the substitution of
one amino acid for another in the COMP protein. Tri-
nucleotide expansion at the region encoding type III
CLRs of the protein has now been reported in this study
and one other previous study [31]. Genotype-phenotype
studies revealed that mutations in CLR7 were associated
with more severe PSACH phenotypes than those in else-
where in the CLRs [21]. The early onset characteristics
of PSACH, severe short stature, generalized dysplasia of
epiphyses and metaphyses, in these individuals with
mutations in other CLRs continues to enforce the
importance of the COMP gene.
COMP is a multifunctional structural protein that
affects cellular attachment, proliferation and chondro-
genesis. It also participates in the ECM assembly
through interactions with numerous proteins including
types I, II, IV, XI, XII collagen, decorin, fibronectin and
matrilin-3 [32,33]. According to the newly published
crystal structure of the COMP protein [27], the
p.451V_452PinsVPG was located to a pocket structure
in the end of the sixth CLR of the COMP protein,
where a calcium ion is embedded. Calcium supports the
binding of COMP to fibronectin which reportedly influ-
ences the conformation of COMP [32]. Specifically,
alterations in CLRs make calcium-dependant protein
folding malfunction [11,30,32,34-37], lead to the assem-
bly of mutant COMP and other proteins in the rER of
affected chondrocytes [33]. This intracellular retention is
cytotoxic and prevents efficient secretion of these pro-
teins, alters the extracellular matrix and results in pre-
mature chondrocyte death. Eventually, the upregulated
apoptosis of chondrocytes from the growth plate
diminishes linear growth, and the abnormal ECM causes
early onset osteoarthritis observed in PSACH patients
[1,38-40]. In PSACH, only a small fraction of COMP
pentamers (3% or less) contains all wild-type COMP
subunits, most of the COMP pentamers contain one or
more mutant subunits that exert dominant negative
effects [8,30]. A mouse model built by Posey et al. reca-
pitulated this cellular pathology of human PSACH,
including the retention of ECM proteins, intracellular
matrix formation in the rER cisternae, and increased
apoptosis of chondrocyte [11]. Previous studies have
shown that calcium-binding is critical in the function of
the COMP protein, and missense mutations or in-frame
deletions in the calmodulin-like repeats region reduces
this ability [1]. The longer amino acids sequence in
CLR6 due to this novel mutation may have similar nega-
tive effects on the function of the COMP protein, the
proliferation and apoptosis of chondrocytes. This study
suggests that the 9 bp insertion can be responsible for
the severe phenotype in the Chinese family in despite
no direct functional evidence. In conclusion, the
c.1352_1352insTGTCCCTGG within exon 13 of COMP
expands the spectrum of mutations that causes PSACH.
It could be of value to the molecular diagnosis,
Figure 2 Similar radiographic features for individual III1 and IV2. (A) Anterior beaking of the vertebral bodies and distinctive plantyspondyly,
mild lumber lordosis. (B) Short metacarpals and phalanges, small carpal bones, cone-shaped epiphyses, irregular metaphyses of the ulna and
radius. (C) Mild scoliosis, small femoral heads, flared metaphyseal borders, poorly developed acetabulae with enlarged acetabular angles, and
widened symphysis pubis.
Figure 3 The mutation, c.1352_1353insTGTCCCTGG, in exon 13
of COMP gene. (A) Normal DNA fragment encoding animo acids
Thr-Val-Pro-Asn; (B) mutant sequence encoding animo acids Thr-Val-
Val-Pro-Gly-Pro-Asn.
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pathogenesis of this disorder.
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